E-cadherin autoantibody profile in patients with pemphigus vulgaris

22Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background Pemphigus vulgaris (PV) is an autoimmune skin blistering disease. The main targets of autoantibodies are the desmosomal proteins desmoglein (Dsg)3 and Dsg1. Anti-E-cadherin antibody is the second most frequent antibody found in pemphigus foliaceus (fogo selvagem), but the frequency in PV is unknown. Objectives To determine the anti-E-cadherin antibody profile in the two major subtypes of PV: mucosal PV (mPV) and mucocutaneous PV (mcPV). Methods Sera from 80 patients with PV and 80 controls were tested. Patients with PV were subdivided into mPV (n = 18) and mcPV (n = 62). Samples were tested by E-cadherin, Dsg1 and Dsg3 enzyme-linked immunosorbent assays (ELISAs), and immunoprecipitation coupled with Western blotting (IP-WB). Results Both mPV and mcPV sera have antibodies against E-cadherin as demonstrated by ELISA and IP-WB. Both subtypes of PV have low levels of anti-E-cadherin antibodies, but significantly higher levels than healthy controls by ELISA (P < 0·0001). No difference exists in antibody levels between subgroups (P = 0·82). By IP-WB, 78% of mcPV sera reacted to E-cadherin, vs. 33% of mPV sera tested. Correlation analysis suggests a moderate correlation between anti-E-cadherin antibodies and Dsg1antibodies (average r = 0·61), but no correlation with Dsg3 antibodies (average r = 0·19). Patients with mPV can have lower levels of Dsg1 antibodies compared with controls by ELISA (P < 0·0001). A few mPV sera also reacted to Dsg1 protein by IP-WB (17%). Conclusions Anti-E-cadherin antibodies are present in both major subtypes of PV. A moderate correlation exists between E-cadherin and Dsg1 antibodies. Patients with mPV can have low levels of both E-cadherin and Dsg1 antibodies. What's already known about this topic? The prevalence of anti-E-cadherin antibodies in pemphigus vulgaris (PV) is largely unknown. Only patients with mucocutaneous PV (mcPV) have been reported to have anti-E-cadherin antibodies. Cross-reactivity between E-cadherin and desmoglein (Dsg)1 antibodies has been suggested. What does this study add? We showed that anti-E-cadherin antibodies are present in both mcPV and mucosal PV (mPV). Moderate correlation was found between Dsg1 and E-cadherin antibodies. mPV can have anti-Dsg1 antibodies, suggesting that the distinction between mPV and mcPV based on the autoantibody profile is not clear. © 2013 British Association of Dermatologists.

Cite

CITATION STYLE

APA

Oliveira, M. E. F., Culton, D. A., Prisayanh, P., Qaqish, B. F., & Diaz, L. A. (2013). E-cadherin autoantibody profile in patients with pemphigus vulgaris. British Journal of Dermatology, 169(4), 812–818. https://doi.org/10.1111/bjd.12455

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free